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Objectives. We examined whether reflex neurohormonal con- 
strictor forces attenuate the vasodilator action of nitroglycerin on 
large peripheral conductance vessels. 
Background. Continuous nitroglycerin therapy is associated 
with the development of early tolerance with respect to its 
hemodynamic effects. It remains to be demonstrated whether 
vascular tolerance of large conductance vessels is an important 
contributory factor. 
Methods. Radial artery diameter and forearm blood flow veloc- 
ity were measured before and 24 and 48 h after continuous 
intravenous nitroglycerin infusion (0.5 pg/kg body weight per 
min) in 10 patients with coronary artery disease (mean age -+ 
SEM 59 --. 4 years) by using a high resolution ultrasound evice. 
Blood flow (ml/min) was calculated from mean blood flow velocity 
and cross-sectional rea. 
Results. Increasing concentrations of nitroglycerin led to a 
dose-dependent i crease in radial artery diameter (maximal +24 -+ 
2%) and heart rate. Forearm vascular resistance and forearm blood 
flow were unchanged. After 24 and 48 h of treatment, additional 
nitroglycerin did not further increase radial artery diameter, indi- 
cating that the nitroglycerin-induced ilation of the radial artery was 
maintained and was still maximal. In addition, radial artery diame- 
ter measured before and after 48 h of nitroglycerin infusion and after 
withdrawal of nitroglycerin in five additional patients showed that, 
after withdrawal, arterial diameter returned to baseline values within 
35 min. Plasma renin activity and serum aidosterone and vasopres- 
sin levels increased significantly at 24 and 48 h, accompanied by a 
decrease in hematocrit. 
Conclusions. Continuous intravenous administration of nitro- 
glycerin exerts a sustained vasodilator effect for 48 h in large 
conductance vessels. Neurohormonal ctivation and compensa- 
tory intravascular volume expansion do not attenuate the vasodi- 
lator effects of nitroglycerin on peripheral conductance vessels 
during the 1st 48 h of treatment. 
(J Am Coil Cardiol 1995;26:50- 6) 
The anti-ischemic effects of nitroglycerin are blunted within 
24 h of its continuous intravenous infusion (1-3). This finding 
appears to be due in part to reflex activation of neurohormonal 
vasoconstrictor mechanisms that may serve to counteract the 
arterial and venous effects (4-6). In addition, chronic exposure 
of isolated vessels to nitroglycerin is associated with desensiti- 
zation of vascular smooth muscle, although the precise intra- 
cellular mechanisms remain controversial (7-12). Recent ex- 
perimental and clinical data (13,14) have shown that the 
administration of angiotensin-converting enzyme inhibitors 
and diuretic agents might prevent he development of toler- 
ance. These data point to a substantial contribution of neuro- 
hormonal adjustments o the blunting of nitroglycerin effects in 
vivo. However, it remains to be established whether reflex 
activation of neurohormonal systems limits the vasodilator 
potency of nitroglycerin in large arterial conductance vessels. 
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To address this question, we used a recently developed, high 
precision A-mode ultrasound device to accurately measure 
radial artery diameter, blood flow velocity and systemic hemo- 
dynamic variables during a 48-h continuous intravenous infu- 
sion of nitroglycerin in patients with coronary artery disease. 
Methods  
Study patients. The study group comprised 25 patients (24 
men, 1 woman; mean age 57 years, range 39 to 75) with stable 
coronary artery disease. Exclusion criteria were unstable an- 
gina pectoris, recent myocardial infarction (<4 weeks), New 
York Heart Association functional class III or IV heart failure, 
significant valvular heart disease or a previous history of nitrate 
intolerance. Vasodilators (nitrates, calcium antagonists, angio- 
tensin-converting enzyme inhibitors) and beta-adrenergic 
blocking agents were discontinued _>24 h before the study. In 
a protocol to determine radial artery diameter, blood flow, 
heart rate and blood pressure as well as neurohumoral vari- 
ables before and 24 and 48 h after continuous intravenous 
nitroglycerin i fusion, 10 patients (Group I, mean age [_+SEM] 
59 : 4 years) participated. In 10 additional patients (Group II, 
mean age 53 _+ 4 years, 9 men and 1 woman) dose-response 
curves of nitroglycerin-induced vasodilation of the left anterior 
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descending coronary artery were obtained. In five patients 
(Group IIl), long-term nitroglycerin i fusion was performed 
over 48 h in a dose of 0.5 txg/kg body weight per rain, and radial 
artery diameter was measured before and after 48 h of 
nitroglycerin i fusion and after withdrawal of nitroglycerin. 
After the infusion was stopped, radial artery diameter was 
measured every 30 s until it reached baseline values. 
Determination of radial artery diameter, forearm blood 
flow and systemic hemodynamic variables. The left forearm 
was fixed in a smooth plastic splint. The diameter of the radial 
artery was determined with a recently developed A-mode 
ultrasound echo-tracking device (Asulab, Neuchatel, Switzer- 
land). A thorough description of this device and its features 
has been reported (15-18). Briefly, the apparatus consists of an 
A-mode ultrasound echo-tracking device with a precision 
of _+2.5/xm. The degree of resolution is achieved by averaging 
16 consecutive measurements yielding 312 data points/s. The 
recordings were obtained with a 10-MHz probe positioned 
perpendicularly over the artery. The diameter of the radial 
artery was measured at a mean distance of 7 cm from the wrist. 
An 8-MHz continuous wave Doppler probe (Typ Vasocope III, 
Kranzbuehler, Solingen, Germany) was positioned over the 
radial artery just proximal to the 10-MHz probe to measure 
blood flow velocity. Velocity was monitored continuously and 
recorded on videotape. Blood flow was calculated from mean 
blood flow velocity and cross-sectional rea derived from the 
arterial diameter and assuming acircular vessel. Arterial blood 
flow was expressed in ml/min. Arterial blood pressure and 
heart rate were monitored continuously and noninvasively 
throughout the studies by using a commercially available 
photoplethysmograph (O meda 2300 Finapres) applied to the 
middle finger of the contralateral arm. Forearm vascular 
resistance (R) was calculated from mean blood pressure 
(MAP) and blood flow (BF) according to the equation R = 
MAP/BF (ram Hg/ml per rain). 
Quantitative coronary angiography. During routine coro- 
nary angiography in 10 of the 25 patients (Group II), dose- 
response curves of nitroglycerin-induced vasodilation of the 
left anterior descending coronary artery were performed. 
These patients had no angiographically visible stenosis of this 
artery. The lumen diameter of the midportion of the artery was 
measured before and during increasing intravenous doses of 
nitroglycerin. The cineangiograms were taken with a biplane 
multidirectional isocentric radiographic system (Siemens Bi- 
cor, Erlangen, Germany). Biplane cineangiograms were re- 
corded at a frame rate of 25 frames/s. End-diastolic ine 
frames were videodigitized and stored in the image analysis 
system (Mipron I, Kontron Electronics, Eching, Germany) in a 
512 x 512 matrix with an 8-bit gray scale, as previously 
described (19,20). Automatic ontour detection was performed 
by a geometric edge differentiation technique (19,21). 
Study protocol (Group I). The radial artery, was investi- 
gated before the study by duplex sonography in all patients in 
Group I, and there was no evidence of atheroselerosis in this 
vessel. Radial angiograms were not performed. 
The fasting patients were studied in the supine position at 
8:00 AM. A venous catheter was placed into the antebrachial 
vein of the right arm. After a 30-rain rest period, blood samples 
were collected for measurements of levels of plasma renin 
activity, serum aldosterone and vasopressin and hematocrit. 
Nitroglycerin was infused at increasing doses (0.015, 0.05, 0.15, 
0.5 and 1.5 ~g/kg per rain), 7 rain at each dose at a constant 
volume rate of 1.7 ml/min. Blood flow velocity was measured 
continuously and diameter every 30 s. The measurements 
obtained uring the last minute of each infusion during steady 
state conditions are reported. Thereafter, a nitroglycerin fu- 
sion was started at a dose of 0.5 ~g/kg per rain and continued 
for 48 h. This nitroglycerin dose was chosen because pilot 
studies had indicated that it led to near maximal dilation of the 
radial artery and was well tolerated by all patients. Nitroglyc- 
erin dose-response curves were repeated after 24 and 48 h. 
Plasma renin activity and serum vasopressin and aldosterone 
were measured at baseline and after 24 and 48 h by a 
previously described radioimmunoassay technique (22). 
Statistical analysis. All data are expressed as mean 
value + SEM. Statistical comparisons of vessel diameter and 
blood flow between the nitroglycerin doses, as well as changes 
from baseline to 24 and 48 h and changes after cessation of the 
nitroglycerin i fusion, were made by analysis of variance for 
repeated measures followed by Student t test with the Bonfer- 
roni correction for the number of comparisons. In addition, a 
linear regression approach for diameter changes due to differ- 
ent doses of nitroglycerin and for day to day variability was 
performed. Statistical comparisons between the dose of nitro- 
glycerin that caused half-maximal dilation (EDs0) of the radial 
artery and the EDs0 of the left anterior descending coronary 
artery were performed by Student t test for unpaired observa- 
tions. A p value < 0.05 was considered to indicate statistical 
significance (23). 
Resu l ts  
Effects of nitroglycerin on radial artery diameter, flow, 
blood pressure and heart rate. The infusion protocol is shown 
in Figure 1. Nitroglycerin caused adose-dependent dilation of 
the radial artery diameter (Fig. 2). There was a significant 
increase of heart rate in response to nitroglycerin (+10 _+ 
2.5%, Table 1), consistent with reflex activation of the sympa- 
thetic nervous system. However, there was no significant 
change in forearm blood flow or forearm vascular resistance. A 
trend toward reduced mean arterial pressure did not reach 
statistical significance (Table 1). After the dose-response titra- 
tion, nitroglycerin was given intravenously for 48 h in a 
concentration f 0.5 ~g/kg per rain (Fig. 1). As shown in Figure 
2, the radial artery was still maximally dilated at 24 and 48 h. 
At 24 and 48 h, additional intravenous nitroglycerin chal- 
lenge therefore did not cause significant changes in radial 
artery diameter (24 h, +2.1 - 1%; 48 h, +1.4 + 1%; p = 
NS) (Fig. 3). 
Table 2 depicts the data of five patients (Group III), 
assessed before and after 48 h of nitroglycerin i fusion and 
after withdrawal of nitroglycerin. After 35 rain radial artery 
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B1 Baseline I (before NTG) I : 0.015 gg/kg/min NTG i.v. for 7 min 
B 2 Baseline 2 (before NTG) II : 0.05 gg/kg/min NTG i,v. for 7 min 
B 3 Baseline3(beforeNTG) III :0.15 ~g/kg/minNTGi.v. fo r7min  
* Collection of blood IV : 0.5 gg/kgJmin NTG i.v. for 7 min 
samples V : 1.5 gg/kg/min NTG i.v. for 7 min 
Figure 1. Schematic representation f the protocol. After a 30-rain 
rest period (Bj), blood samples were collected for analysis of plasma 
renin activity, serum aldosterone and vasopressin and hematocrit. 
Then nitroglycerin (NTG) was infused intravenously (i.v.) in increasing 
concentrations for 7 min each. Blood flow and diameter data represent 
measurements during the last minute of each infusion during steady 
state conditions. Thereafter, a 48-h nitroglycerin fusion was started 
at a concentration f0.5/xg/kg per min. The dose-response curves for 
nitroglycerin were repeated during continuous long-term nitroglycerin 
infusion at 24 and 48 h. B 2 and B 3 = measurement of radial artery 
diameter and flow at 24 and 48 h, respectively. 
diameter was not significantly different from baseline values. 
Blood flow did not change significantly. Recovery of mean 
arterial blood pressure and heart rate was observed within 
5 min after the nitroglycerin i fusion was stopped. 
Forearm blood flow tended to be lower than preinfusion 
values 24 and 48 h after initiation of nitroglycerin infusion. 
Forearm vascular resistance did not change significantly. A 
trend toward reduced mean arterial pressure and increased 
heart rate at 24 and 48 h did not reach statistical significance 
(Table 1). 
Effects of nitroglycerin infusion on neurohumoral variables 
and hematocrit. The data are reported in Table 3. Twenty- 
four hours after the start of the nitroglycerin i fusion there was 
a significant increase in plasma renin activity and serum 
Figure 2. Mean absolute values and SEM (bars) of radial artery 
diameter (in mm) at baseline (B, solid column), after 24 h (hatched 
eolumn) and after 48 h (open column) of long-term nitroglycerin 
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aldosterone and vasopressin from control values. Hematocrit 
decreased from 44.1 + 2 to 42.3 _+ 1 (p < 0.05) over 24 h. After 
48 h the increase in aldosterone l vels was maintained. Plasma 
vasopressin and renin activity partly decreased but remained 
above baseline values. There was a further significant reduc- 
tion in plasma hematocrit to 40.8 _+ 2% (p < 0.05 vs. 24 h and 
vs. baseline). 
Comparison of nitrate sensitivity of the radial artery and 
the left anterior descending coronary artery. At baseline, the 
dose of nitroglycerin that caused half-maximal dilation (EDso) 
of the radial artery, as determined by the forearm high 
precision ultrasound method, was 0.12 _+ 0.01 /~g/kg/min 
(Group I, n = 10). In 10 different patients (Group II), the 
EDso for the dilator response of the left anterior descending 
artery to intravenous nitroglycerin was 0.13 ___ 0.03/xg/kg per 
rain, respectively (p = NS vs. radial artery; Fig. 4). This 
observation indicates a similar nitrate sensitivity of coronary 
and peripheral large conductance vessels. 
Day to day variability. To study the day to day variability of 
the radial artery diameter and flow, eight additional subjects 
(mean age 41 _+ 6 years, four patients with coronary artery 
disease and four healthy volunteers) were investigated on 2 
consecutive days at the same time of day. Radial artery 
diameter and blood flow were determined by the ultrasound 
method as described earlier. The radial artery diameter was 
2.79 _+ 0.10 mm on day 1 and 2.80 _+ 0.13 mm on day 2 (r = 
0.96, p < 0.001). Blood flow was 17.8 _+ 2.9 ml/min on day 1 
and 16.1 _ 3.3 ml/min on day 2 (r = 0.88, p < 0.01). 
Discuss ion  
This study demonstrates that the vasodilator esponse to 
nitroglycerin i large conduit vessels is maintained over a 48-h 
period of a continuous intravenous infusion, despite systemic 
neurohumoral ctivation. These findings indicate that reflex 
neurohormonal constrictor forces do not attenuate the vaso- 
dilator action of nitroglycerin on large peripheral conductance 
vessels. 
Mechanisms of nitrate tolerance. The beneficial clinical 
effects of nitroglycerin are rapidly blunted during continued 
administration. Hemodynamic tolerance develops as early as 
24 h after the initiation of a sustained infusion of nitroglycerin 
(1-3) and might be due to an impaired intracellular nitro- 
glycerin biotransformation (true vascular tolerance) or to a 
reflex activation of neurohormonal vasoconstrictor forces 
(pseudotolerance) limiting the vasodilator potency of nitro- 
glycerin on veins, arteries or arterioles. 
Recent clinical and experimental work has identified a role 
for neurohormones and intravascular volume in the mecha- 
nism of tolerance: A nitrate-flee interval of 12 h prevented 
neurohormonal ctivation and the development of hemody- 
namic tolerance (2,24). The beneficial effects of angiotensin- 
converting enzyme inhibitors on the exercise tolerance of 
patients with stable coronary artery disease provides indirect 
evidence that neurohormonal djustments are able to attenu- 
ate the anti-ischemic effects of nitroglycerin (14). It is unclear, 
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Table 1. Heart Rate, Blood Pressure, Blood Flow and Forearm Resistance in Response to Short-Term Nitroglycerin I fusions 
Nitroglycerin (tW'kg per ±in)  
Baseline 0.1115 11.05 0.15 0.5 1.5 
Blood Flow (ml/min) 
0 h 17.7 -+ 2.8 18.3 - 2.7 18.8 : 2,8 18.7 ± 2.3 19.1 _+ 2.2 18.9 ± 2.2 
24 h 13.8 - 1.8 13.2 + 1.9 13.3 + 1.4 12.6 2 1.4 11.8 _+ 1.4 10.6 ± 1.3 
48 h 13.8 _+ 1.6 12.5 + 1.9 10.9 ± 1.7 I 1.6 -+ 1.6 12.6 ± 2.1 9.9 + 1.9 
Mean Arterial Blood Pressure (mm Hg) 
0 h 94.4 + 2.5 95.0 - 2,5 92.1 ± 3.6 96.2 : 3.3 93.0 _+ 3.5 89.0 _+ 2.5 
24 h 90.9 - 3.0 92.q ~ 3,7 92.9 : 3.3 93.5 ± 3.1 91.9 _+ 3.1 90.3 ± 2.4 
48 h 89.9 + 5.3 91.8 + 5,4 90.8 ± 5.4 89.3 + 5.3 88.9 + 4.4 85.0 _+ 3.8 
Forearm Resistance (ml/min ×mm Hg) 
0 h 6.9 + 1.3 6.7 _+. 1.3 6.9 + 1.8 7.2 + 2.0 6.1 : 1.1 5.2 +_ 0.8 
24 h 7.9 + 1.0 8.6 - 1.2 8.11 = 1.1 8.3 : 0.9 9.2 -- 1.4 10.1 ± 1.7 
48 h 7.8 - 1.3 t).4 ~ 1.6 10.9 : 1.8 9.6 ± 1.7 9.1 ± 1.7 11.8 ± 1.3 
Heart Rate (beats/min) 
0 h 66,6 + 3.7 66.8 + 3.4 67,0 + 3.4 68.8 + 3.5 71.0 _+ 3.6 73.5 + 3.8* 
24 h 69.9 _+ 3.9 71.5 + 3.9 72.9 _+ 4.11 71.7 + 3.7 73.9 ± 4.3 76.0 ± 4.8 
48 h 74.2 -+ 4.1 75.2 + 4.0 74./i ± 4.1 74.6 +_ 4.6 76.8 ± 4.7 76.7 = 4.8 
*p < 0.05 versus baseline (before the start of nitroglycerin infusion). Data arc cxpresscd as mean value + SEM. 
however, which vessel region on the arterial side (large arteries 
vs. arterioles) is primarily affected by the reflex activation of 
neurohormonal vasoconstrictor forces during nitroglycerin 
therapy. 
In the present study, 24 and 48 h after initiation of 
nitroglycerin infusion, the radial arte~, diameter was still 
maximally dilated and additional intravenous nitroglycerin 
failed to cause further dilation. These observations together 
with the decrease in diameter after withdrawal of nitroglycerin 
Figure 3. Effects of the nitroglycerin (NTG) infusions on arterial diame- 
ter. Data are expressed aspercent changes inmean radial arte~' diameter 
and SEM (bars) before (solid columns), after 24 h (hatched columns) 
and after 48 h of nitroglycerin infusion (open columns). *p < 0.01 versus 
baseline and versus nitroglycerin 0.015 ~g/kg per rain. +p < 0.05 versus 
nitroglycerin 0.05 gg/kg per min. Results of the regression a alysis: Before 
long-term nitroglycerin i fusion, the slope (dose of nitroglycerin vs. 
diameter) was 12.55 + 1.58 (p < 0.0001 [two-tailed]); after 24 h it was 
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indicate a sustained maximal dilation of the radial artery 
during 48 h of nitroglycerin infusion. Plasma renin activity, 
plasma aldosterone and vasopressin levels increased signifi- 
cantly, indicating neurohumoral activation, whereas plasma 
hematocrit decreased, indicating intravascular volume expan- 
sion. 
These data are consistent with previous data of Mtinzel et 
al. (25) obtained in a dog model of nitrate tolerance, In that 
study the increase in circumflex artery diameter in response to 
nitroglycerin was lost after 2 to 3 days of a prolonged nitro- 
glycerin infusion. Recent preliminary observations from our 
group (26) show that after 24 h of nitroglycerin infusion, 
neurohormonal djustments do not attenuate the epicardial 
coronary artery vasodilator effects of nitroglycerin. Collec- 
tively, these data show that increased levels of angiotensin II
and vasopressin do not override the vasodilator effects of 
nitroglycerin on peripheral conductance vessels during the 1st 
48 h of administration. 
Despite these potent vasodilator effects on conductance 
vessels intravenous nitroglycerin (in concentrations of 0.015 to 
1.5 /xg/kg per min) did not affect forearm blood flow. This 
observation is in keeping with recent experimental data show- 
ing that nitroglycerin is a potent dilator of larger coronary 
vessels (diameter >100/xm) with minimal effects in arteries 
<100/xm in diameter (27,28). Boesgaard et al. (29) found that 
subcutaneous blood flow was not significantly affected by 
infusion of 0.1/xg/kg per ±in nitroglycerin. 
The neurohormonal ctivation during nitroglycerin fusion 
demonstrated in the present study is consistent with previous 
reports (2,24). In contrast, Parker and Parker (30) found that 
continuous cutaneous delivery of nitroglycerin at a dose of 
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Table 2. Radial Artery Diameter, Blood Flow, Mean Arterial Blood Pressure and Heart Rate at 
Baseline, After 48 h of Nitroglycerin I fusion and Repetition of the Dose-Response Curve and After 
Withdrawal of Nitroglycerin i  Five Patients 
Radial Artery. Mean Arterial 
Diameter Blood Flow Blood Pressure Heart Rate 
(mm) (ml/min) (mm Hg) (beats/min) 
Baseline 
After 48 h of NTG 















2.50 -+ 0.04 10.9 + 1.43 89.8 -+ 2.7 63.8 _+ 1.0 
3.39 -+ 0.09* 14.5 + 2.4 78.4 _+ 1.9" 73.0 _+ 1.4" 
3.29 _+ 0.10" 11.4 _+ 2.2 85.2 _+ 1.6 66.8 _+ 1.6 
3.13 = 0.12" 11.5 + 1.8 92.2 ± 2.9 66.4 -+ 1.3 
3.03 = 0.10" 12.6 -+ 1.9 89.2 -+ 2.3 65.4 _+ 1.2 
2.99 _+ 0.10' 13.7 _+ 1.9 88.4 _+ 2.4 65.6 -+ 1.2 
2.90 _+ 0.09* 15.2 _+ 2.2 90.6 _+ 2.1 64.0 + 1.l 
2.73 _+ 0.08* 9,8 -+ 1.2 98.0 -+ 3.0 65.8 _+ 1.3 
2.66 + 0.05 10.2 = 1.7 95.0 _+ 1.8 67.2 = 1.4 
2.66 + 0.04 9.5 _+ 1.3 90.0 _+ 2.2 63.0 + 1.2 
2.60 _+ 0.04 I2.9 + 2.1 89.4 z 1,7 65.8 _+ 1.2 
2.62 z/).04 13.5 _+ 2.1 92.2 _+ 1,7 67.6 _+ 1.6 
2.59 + 0.03 13.5 -+ 2.2 90.2 _+ 2.1 64.8 -+ 1.6 
2.60 -+ 0.04 11.8 _+ 1.7 89.2 _+ 1.1 65.6 _+ 1.5 
2.53 -+ 0.04 13.2 _+ 2.1 88.6 + 1.1 66.8 2 1.5 
2.50 -+ 0.03 12.5 +_ 2.2 89.0 _+ 1.3 63.6 _+ 1.3 
*p < 0.05 versus baseline values. Data are expressed as mean value = SEM. NTG = nitroglycerin. 
0.6 mg/h in patients with stable coronary artery disease caused 
no change in neurohormonal activity but was associated with 
changes indicating volume expansion. This discrepancy with 
the present data is likely be attributed to the investigational use 
of a lower nitroglycerin concentration than that used in our 
study. We found that an average dose of 2.08 mg/h of 
intravenous nitroglycerin causes a significant increase in 
plasma renin activity, plasma aldosterone and vasopressin 
levels over a 48-h period. 
Methodologie considerations. One distinctive feature of 
the present study was the use of a novel high-fidelity ultra- 
sound device to measure forearm arterial diameter that al- 
lowed us to assess noninvasively the dimension of a peripheral 
conductance vessel with a high degree of precision. The 
accuracy of this A-mode echo-tracking device has been inves- 
tigated in previous tudies (16-18). Mooser et al. (16) assessed 
the reproducibility of the measurement of radial artery diam- 
eter by the A-mode echo-tracking device. They carried out 
seven separate determinations of radial artery diameter in 10 
subjects over a 5-h period, repositioning the transducer before 
Table 3. Plasma Renin Activity, Serum Aldosterone and 
Vasopressin and Hematocrit Before and After 24 and 48 h of 
Nitroglycerin I fusion 
Aldosterone Renin Vasopressin Hematocrit 
(pb/ml) (ng/ml per h) (pg/ml) (%) 
0 h 69 ± 10 0.87 ± 0.3 3.1 + (I.5 44.1 _+ 2 
24h 109_+18 * 1.34+0.3 * 21.5 _~ 2.3 * 42.3_+1' 
48h  97_  + 15' 1.02_+0.2 I1.2 + 1.9" 40.8_~ l*t 
*p < 0,05 versus baseline value (0 h), before the start of nitroglycerin 
infusion, tp < 0.05 versus value at 24 h. Data are expressed as mean value 
SEM. 
each reading. In a given individual, the standard error from the 
mean diastolic diameter ranges between 30 and 200/xm. These 
variations include both the actual fluctuations in arterial 
diameter during the day and the potential positioning error. 
The high reproducibility of the diameter-pressure curve mea- 
surements was also reported in a study (17) measuring data in 
10 volunteers during two sessions that took place at the same 
time of day within a 9-day period; the diameter-pressure curves 
could be superimposed. The theoretic resolution on the diam- 
eter evolution is 2.5 ~m, which has been confirmed by refer- 
ence targets (18). We found a low day to day variability of 
radial artery diameter and flow in eight subjects who were 
studied on 2 consecutive days at the same time. Thus, this 
echo-tracking device may serve as a valuable clinical tool to 
determine the time course of vascular tolerance in peripheral 
conductance v ssels in response to a prolonged nitroglycerin 
infusion. 
Limitations of the study. It is well known that nitroglycerin 
causes a dose-dependent decrease in blood pressure (31,32) 
but with individual variations (31,33). In our study a trend 
toward reduced mean arterial pressure did not reach statistical 
significance. In 8 of 10 patients mean blood pressure de- 
creased, in 1 patient it remained unchanged and in 1 patient it 
increased. This increase was out of the range of 2 SD of the 
mean change of blood pressure in the study group. In the 
remaining nine patients acute administration of nitroglycerin 
reduced mean arterial blood pressure from 96.0 _+ 2.1 mm Hg 
to 88.0 _+ 2.4 mm Hg (p < 0.05 vs. baseline). We cannot explain 
the increase in blood pressure in one patient despite the 
infusion of clearly hypotensive doses of nitroglycerin (31-33). 
Because there was no clear reason to exclude this patient, we 
reported the data of all 10 patients tudied, but grouped ata 
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Figure 4. Comparison of the calculated nitroglycerin concentration 
(EDso) that caused half-maximal di ation of the radial artery (RAD) 
with the EDso of the left anterior descending coronary artery (LAD). 
(p = NS.) 
might mask individual response. We therefore performed a
separate analysis of nine patients and found a dose-response 
curve of blood pressure to increasing doses of nitroglycerin 
similar to the reported findings after acute administration. 
Blood pressure remained low during 24 h of the nitroglycerin 
infusion (86 +- 3 mm Hg after 24 h) (31-33). 
Blood pressure was measured noninvasively b  the Finapres 
method, which has been validated by lmholz et al. (34) and 
Parati et al. (35). The average discrepancy between finger and 
intraarterial blood pressure recorded over a 30-rain rest period 
was 6.5 _+ 2.6 mm Hg and 5.4 _+ 2.9 mm Hg for systolic and 
diastolic blood pressure (35) and -3 2 7 mm Hg for mean 
blood pressure during "standing up" maneuvers (34). Thus, 
the variability of the Finapres method compared to invasive 
measurements is <5% regarding mean and systolic arterial 
blood pressure in these studies. 
We did not measure intramural collateral and microcircu- 
latory flow. Microsphere flow data in animals and humans 
(36-38) have shown an increase in intramural collateral and 
microcirculatory flow with nitroglycerin. We observed that a 
dose of 0.5 /xg/kg per min of nitroglycerin was sufficient o 
cause maximal dilation of conduit vessels but was associated 
with no change in blood flow, indicating no effect of this 
intravenous nitroglycerin i fusion on resistance vessels. Nitrate 
sensitivity of the radial artery was compared to that of the 
coronary conductance arteries by calculating the nitroglycerin 
concentration (EDso) that caused half-maximal dilation of the 
radial artery in 10 patients (Group 1, mean age 59 -+ 4 years) 
and of the left anterior descending coronary artery in an 
additional 10 patients with coronary artery disease (Group II, 
mean age 53 _+ 4 years). Thus, these calculations were made in 
two different patient groups. We did not investigate the dose 
response to nitroglycerin i  the coronary circulation after 48 h. 
We are therefore not able to compare the ED50 at this time. A 
similar ED50 before the infusion of nitroglycerin does not 
imply the existence of a similar responsiveness after the 
infusion for 48 h. 
Clinical implications. Long-term infusion of nitroglycerin 
is widely used in patients with unstable angina pectoris or acute 
myocardial infarction, but early loss of its hemodynamic, 
anti-ischemic and antianginal effects limits the efficacy of this 
approach (31,39,40). The present data demonstrate hat the 
vasodilator effects of nitroglycerin on peripheral conductance 
vessels are preserved over 48 h of its continuous administra- 
tion. The similar EDso for radial and epicardial coronary 
arteries indicates acomparable degree of nitrate sensitivity in 
the two vessels. These observations uggest hat the early 
development of nitrate tolerance (within 48 h) is not due to the 
loss of vasodilator effects of nitroglycerin on large conduit 
vessels. Concentrations of nitroglycerin sufficient o cause 
maximal dilation of conduit vessels were associated with no 
change in blood flow, indicating that this dose of intravenous 
nitroglycerin infusion does not affect resistance vessels. In- 
deed, forearm blood flow tended to be lower than baseline 
values after 24 and 48 h of nitroglycerin. Neurohormones such 
as vasopressin and angiotensin II are known to be potent 
constrictors of small resistance vessels (41-43). Thus, the early 
development of nitrate tolerance--regarding its hemodynamic, 
anti-ischemic and antianginal effects (1,31,40)--may reside not 
in vascular tolerance of large conduit vessels but rather in 
tolerance of capacitance vessels (44) and vasoconstriction f
resistance vessels, secondary to neurohumoral ctivation 
(41,43). 
We are grateful to Manfred Olschewski, PhD for statistical advice. 
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